Lake in the Hills, IL, United States of America

Sean Brynjelsen

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignee: Baxter International Inc.. Active years: 2004-2014.


% Patents Active = 100.0


Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 2004-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sean Brynjelsen

Introduction

Sean Brynjelsen is a notable inventor based in Lake in the Hills, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel methods for preparing nanoparticles. With a total of 5 patents to his name, Brynjelsen's work is paving the way for advancements in drug delivery systems.

Latest Patents

Brynjelsen's latest patents include innovative processes that enhance the delivery of poorly water-soluble compounds. One of his key inventions is the "Preparation of submicron sized nanoparticles via dispersion lyophilization." This process involves lyophilizing a dispersion of a multiphase system, which includes an organic phase containing the poorly water-soluble compound. This method is particularly beneficial for preparing nanoparticles suitable for in vivo delivery, especially through parenteral routes.

Another significant patent is titled "Compositions of and method for preparing stable particles in a frozen aqueous matrix." This invention describes a stable suspension of a poorly water-soluble pharmaceutical agent or cosmetic, which is suspended in a frozen aqueous matrix. The composition remains stable for an extended period, making it suitable for various administration routes, including parenteral, oral, and non-oral methods such as inhalation and topical application.

Career Highlights

Brynjelsen is currently employed at Baxter International Inc., a leading global healthcare company. His work at Baxter focuses on developing innovative solutions that address critical healthcare challenges. His expertise in nanoparticle technology is instrumental in advancing the company's pharmaceutical offerings.

Collaborations

Throughout his career, Brynjelsen has collaborated with talented individuals such as James E Kipp and Mark Joseph Doty. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Sean Brynjelsen's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective drug delivery systems, ultimately benefiting patients and the healthcare industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…